LQZ-7I

Overview

LQZ-7I is a survivin -targeting inhibitor. LQZ-7I inhibits survivin dimerization. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Survivin

Product Information

• Catalog No.: HY-136538
• CAS No.: 195822-23-2
• Molecular Formula: C20H14F2N4
• Molecular Weight: 348.35
• Purity: 99.78%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (5.97 mM); Clear solution
• Availability: In-stock

Source

Original product source